Application of antisense oligonucleotides for EWS-Flil in Ewing's sarcoma.
| Project/Area Number |
15591586
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Orthopaedic surgery
|
|---|
| Research Institution | KYUSHU UNIVERSITY |
|---|
Principal Investigator |
TANAKA Kazuhiro Kyushu University, Kyushu University Hospital, Research Associate, 大学病院, 助手 (10274458)
|
|---|
| Project Period (FY) |
2003 – 2004
|
| Project Status |
Completed (Fiscal Year 2004)
|
| Budget Amount *help |
¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 2004: ¥1,600,000 (Direct Cost: ¥1,600,000)
Fiscal Year 2003: ¥1,700,000 (Direct Cost: ¥1,700,000)
|
|---|
| Keywords | Ewing's Sarcoma / EWS-Flil / fusion gene / antisense oligonucleotide / molecular target therapy |
|---|
| Research Abstract |
The translocation t(11;22)(q24:q12) is a specific chromosomal abnormality detected in Ewing's sarcoma(ES). The translocation results in an EWS-Flil fusion gene. Recent studies have evaluated transforming potentials of the fusion gene products acting as an aberrant transcription factor. However, the biological significance of EWS-Flil is still unknown. We have found that there is a correlation between the expression levels of the EWS-Flil fusion gene and the proliferative activities of ES cells. When the EWS-Flil expression was inhibited by an antisense oligonucleotide (AS) against the fusion gene, the growth of the ES cells was significantly reduced both in vitro and in vivo. The flow cytometry analysis indicated that the growth inhibition of the cells by AS was mediated by G1 arrest in the cell cycle progression. In the present study, we aimed to apply AS against EWS-Flil to inhibit the growth of ES in vivo. To identify the most effective AS sequence, we analyzed EWS-Flil mRNA structure using computer software, and determined mRNA loops which were possible targets of AS. We synthesized these AS and examined whether these AS would inhibit ES cell growth in vitro. We obtained the AS sequence which could most effectively inhibit the growth of ES cells. We also confirmed the growth inhibitory effects of AS in vivo. We next examined the effects of AS on the induction ofapoptosis in ES cells. We found that the effects of AS on ES cell line was cytostatic and apoptosis was not induced in ES cells by AS. Thus, we next examined the combination effects of AS and anti-tumor drugs. Cotreatment with AS and topoisomerase inhibitors showed strong induction ofapoptosis in ES cells. These results suggest that the combination chemotherapy with AS and topoisomerase inhibitors would be effective to maximize the antitumor effects on ES in clinical trial.
|
Report
(3 results)
Research Products
(25 results)
-
-
-
-
-
[Journal Article] The prognostic and therapeutic relevance of p27Kip1 in Ewing's family tumors.2004
Author(s)
Tomoya Matsunobu, Kazuhiro Tanaka, Yoshihiro Matsumoto, Fumihiko Nakatani, Riku Sakimura, Masuo Hanada, Li Xu, Yoshinao Oda, Ichiro Naruse, Hideki Hoshino, Hiromasa Miura, Masazumi Tsuneyoshi, Yukihide Iwamoto
-
Journal Title
Clin.Cancer Res. 10
Pages: 1003-1012
Description
「研究成果報告書概要(欧文)」より
Related Report
-
-
-
[Journal Article] E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma.2004
Author(s)
Tsuyoshi Saito, Yoshinao Oda, Ken-ichi Kawaguchi, Keishi Sugimachi, Hidetaka Yamamoto, Naomi Tateishi, Kazuhiro Tanaka, Shuichi Matsuda, Yukihide Iwamoto, Marc Ladanyi, Masazumi Tsuneyoshi
-
Journal Title
Oncogene 23
Pages: 8629-8638
Description
「研究成果報告書概要(欧文)」より
Related Report
-
-
-
-
-
-
-
-
-
[Book] 神中整形外科学改訂22版2004
Author(s)
田仲 和宏, 他(分担執筆)
Total Pages
2124
Publisher
南山堂
Description
「研究成果報告書概要(和文)」より
Related Report
-
-
-
-
-
-
-
-
